Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q May 9, 2019 10-Q
8-K May 8, 2019
DEFA14A May 3, 2019 DEFA14A
DEF 14A May 3, 2019 DEF 14A
8-K Apr 29, 2019 FORM 8-K
8-K Apr 26, 2019 FORM 8-K
4 Apr 5, 2019 FORM 4 SUBMISSION
S-8 Mar 14, 2019 S-8
10-K Mar 14, 2019 10-K
8-K Mar 13, 2019 FORM8K
4 Feb 8, 2019 FORM 4 SUBMISSION
4 Feb 8, 2019 FORM 4 SUBMISSION
4 Feb 8, 2019 FORM 4 SUBMISSION
4 Feb 8, 2019 FORM 4 SUBMISSION
8-K Feb 8, 2019 FORM 8-K
8-K Jan 24, 2019 FORM 8-K
8-K Jan 10, 2019 FORM 8-K
SC 13G Jan 3, 2019
8-K Dec 20, 2018 FORM 8-K
8-K Dec 6, 2018 FORM 8-K
8-K Dec 3, 2018 FORM 8-K
CT ORDER Nov 19, 2018
SC 13G/A Nov 13, 2018
10-Q Nov 7, 2018 10-Q
8-K Nov 7, 2018 FORM 8-K
← Newer Page 21 of 33 · 821 filings Older →